Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Bullboard Posts
Post by fab4everon Nov 06, 2017 9:11am
539 Views
Post# 26910548

McKesson Deal

McKesson DealAs expected... the news release doesn't state what investors want it to say but that's normal for agreements with major multinationals.   I'm surprised they didn't force MARI to file a non disclosure and bury it on SEDAR.  McKesson have over 50% of the retail pharmacy market in Canada with Uniprix, Rexall, Guardian, IDA, Proxim and Remedy's RX, etc... they're in the business of distributing pharmaceuticals, not just front house merch like other major pharmacy in Canada.  With the number of their pharmacies over 3,000 and MARI as a primary provider, which basically means exclusive.  MARI will now have conservative demand at one patient per pharmacy per week being conservative.  That's 150,000 plus patients a year. 
Bullboard Posts